Dhan App
Chrome
Pay ₹0 Brokerage on Investing. Open Free Demat Account with Zero AMC for Life!
+91
Trending
Finnifty
Nifty Bank
Nifty Next 50
Sensex
Smallcap Pharma Stocks
Last Updated on 13 May 2025 at 15:57
Here you get all NSE/BSE small-cap stocks in the pharmaceutical sector. These stocks represent smaller pharmaceutical companies that have growth potential in the healthcare market. Small-cap pharma stocks can be attractive for investors seeking opportunities in the healthcare sector with the potential for high returns, though they also come with higher risks compared to larger pharma companies.
List of Small Cap Pharma Shares
View By:
Name | LTP | Change % | Volume | Market Cap (Cr.)  | PE Ratio | Industry PE | 52W High | 52W Low | 1M Returns | 3M Returns | 1 Yr Returns | 3 Yr Returns | 5 Yr Returns | PB Ratio | Dividend Yield | ROE | ROCE | EPS | 50 DMA | 200 DMA | RSI |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A Ajanta Pharma | 2,592.70 | 4.45% | 1,12,808 | ₹ 32,386 | 33.66 | 37.19 | 3,485.00 | 2,111.05 | -1.16% | 3.89% | 8.93% | 127.02% | 170.66% | 8.55 | 1.14% | 22.88% | 29.96% | 67.81 | 2,594.94 | 2,865.02 | 40.35 |
P Piramal Pharma | 214.84 | 1.34% | 57,50,541 | ₹ 28,482 | 493.75 | 42.09 | 307.90 | 136.10 | -3.45% | 7.12% | 39.33% | 15.79% | 15.79% | 3.55 | 0.05% | 0.23% | 5.74% | 0.30 | 213.20 | 223.92 | 47.52 |
S Suven Pharmaceuticals | 1,081.80 | 1.74% | 1,83,706 | ₹ 27,539 | 96.86 | 42.09 | 1,360.00 | 598.00 | -8.69% | -3.42% | 63.17% | 107.40% | 560.92% | 13.67 | - | 14.64% | 19.24% | 9.45 | 1,143.88 | 1,147.94 | 39.29 |
J J B Chemicals and Pharmaceuticals | 1,582.90 | 1.65% | 1,09,993 | ₹ 24,642 | 37.99 | 42.09 | 2,030.00 | 1,385.75 | -0.54% | -5.99% | -11.73% | 98.83% | 407.05% | 7.57 | 0.78% | 18.90% | 25.46% | 37.83 | 1,588.71 | 1,771.19 | 46.95 |
G Gland Pharma | 1,433.20 | 0.22% | 1,07,812 | ₹ 23,613 | 33.46 | 37.19 | 2,220.95 | 1,277.80 | 0.48% | -2.91% | -18.77% | -52.17% | -21.23% | 2.68 | 1.40% | 8.85% | 12.51% | 43.83 | 1,510.12 | 1,702.21 | 44.37 |
W Wockhardt | 1,276.80 | 0.54% | 4,47,205 | ₹ 20,746 | - | 42.09 | 1,679.90 | 490.15 | -8.95% | -11.12% | 137.79% | 444.13% | 480.73% | 4.70 | - | - | -2.37% | - | 1,332.62 | 1,234.45 | 43.86 |
A AstraZeneca Pharma | 8,189.50 | 0.86% | 9,125 | ₹ 20,474 | 121.08 | 54.22 | 9,211.00 | 5,140.00 | -7.71% | 10.74% | 54.15% | 225.33% | 168.45% | 29.88 | 0.30% | 22.69% | 30.62% | 52.40 | 8,095.90 | 7,286.18 | 44.14 |
P Pfizer | 4,324.00 | 1.76% | 17,567 | ₹ 19,781 | 31.59 | 54.22 | 6,451.15 | 3,701.00 | 3.00% | 3.72% | -0.82% | 1.69% | -1.39% | 5.18 | 0.82% | 15.33% | 20.68% | 131.73 | 4,132.44 | 5,004.26 | 55.51 |
E Eris Lifesciences | 1,444.80 | 2.84% | 2,78,335 | ₹ 19,673 | 57.98 | 37.19 | 1,593.90 | 815.85 | 4.56% | 14.20% | 69.97% | 114.87% | 190.41% | 6.89 | - | 16.85% | 11.43% | 27.95 | 1,357.00 | 1,326.46 | 47.95 |
E Emcure Pharmaceuticals | 1,035.10 | -0.20% | 60,582 | ₹ 19,608 | 32.32 | 42.09 | 1,580.00 | 889.00 | 8.75% | -2.76% | -23.84% | -23.84% | -23.84% | 4.77 | 0.18% | 16.90% | 20.98% | 26.63 | 1,001.14 | 1,265.27 | 52.48 |
O Onesource Specialty Pharma | 1,648.90 | 3.63% | 2,57,102 | ₹ 18,869 | 222.93 | 42.09 | 1,800.00 | 1,209.95 | 5.19% | 14.34% | -3.57% | -3.57% | -3.57% | 3.10 | - | - | -40.74% | - | 1,540.57 | - | 51.00 |
A Alembic Pharmaceuticals | 895.75 | 1.84% | 72,144 | ₹ 17,607 | 30.19 | 42.09 | 1,303.90 | 725.20 | 5.82% | 8.48% | -6.04% | 20.79% | 11.98% | 3.33 | 1.25% | 12.78% | 13.79% | 32.05 | 857.88 | 1,021.02 | 50.59 |
N Neuland Laboratories | 12,587.00 | 0.14% | 22,404 | ₹ 16,149 | 67.10 | 32.36 | 18,100.00 | 5,540.10 | -0.58% | -1.41% | 107.67% | 1,109.18% | 2,931.19% | 11.55 | 0.11% | 23.39% | 29.57% | 249.83 | 11,847.93 | 12,978.38 | 54.81 |
C Concord Biotech | 1,505.70 | -0.36% | 59,506 | ₹ 15,752 | 48.52 | 42.09 | 2,664.00 | 1,327.05 | -13.12% | -28.70% | -0.10% | 59.71% | 59.71% | 9.96 | 0.58% | 20.18% | 26.63% | 29.94 | 1,623.75 | 1,875.74 | 43.00 |
C Caplin Point Laboratories | 2,003.50 | 3.04% | 1,86,283 | ₹ 15,229 | 28.67 | 37.19 | 2,641.00 | 1,225.00 | 4.05% | -0.68% | 53.44% | 183.16% | 520.86% | 5.81 | 0.26% | 19.77% | 23.88% | 62.84 | 1,910.23 | 1,995.62 | 53.56 |
S Sai Life Sciences | 725.55 | 1.61% | 3,51,523 | ₹ 15,099 | 107.76 | 37.19 | 808.80 | 636.10 | -5.90% | 6.72% | -5.11% | -5.11% | -5.11% | 7.45 | - | - | 12.71% | - | 712.56 | - | 50.76 |
N Natco Pharma | 825.10 | -1.04% | 6,36,393 | ₹ 14,778 | 8.01 | 42.09 | 1,639.00 | 726.80 | 2.63% | -15.38% | -15.33% | 20.72% | 36.03% | 2.09 | 1.14% | 14.68% | 28.53% | 91.37 | 818.68 | 1,228.29 | 49.29 |
J Jubilant Pharmova | 907.05 | 3.17% | 1,46,968 | ₹ 14,448 | 41.58 | 32.36 | 1,309.90 | 617.05 | -1.40% | -5.55% | 31.85% | 127.56% | 111.66% | 2.36 | 0.57% | 1.34% | 4.58% | 14.96 | 899.76 | 1,007.37 | 45.01 |
A Alivus Life Sciences | 1,137.30 | 3.38% | 75,933 | ₹ 13,936 | 30.49 | 42.09 | 1,251.00 | 850.00 | 14.69% | 10.84% | 4.88% | 4.88% | 4.88% | 5.30 | 2.05% | 21.84% | 26.24% | 36.48 | 1,035.92 | 1,060.81 | 57.43 |
S Sanofi | 5,930.00 | 1.31% | 10,593 | ₹ 13,657 | 30.50 | 54.22 | 10,524.95 | 4,902.00 | -4.10% | 10.32% | -25.83% | -12.21% | -24.83% | 15.67 | 2.00% | 59.39% | 48.50% | 213.31 | 5,806.24 | 6,209.36 | 45.09 |
B Blue Jet Healthcare | 769.00 | 4.68% | 4,00,826 | ₹ 13,339 | 54.27 | 42.09 | 968.30 | 347.60 | 4.42% | 1.02% | 108.03% | 86.02% | 86.02% | 13.78 | 0.14% | 39.96% | 50.91% | 9.47 | 782.00 | 607.12 | 48.43 |
G Granules | 477.75 | 3.82% | 18,95,461 | ₹ 11,585 | 23.27 | 42.09 | 721.00 | 389.35 | 2.87% | -11.89% | 17.90% | 99.81% | 205.76% | 3.25 | 0.33% | 12.57% | 18.99% | 20.30 | 474.69 | 561.33 | 48.12 |
S Sanofi Consumer Healthcare | 4,905.70 | 0.01% | 2,580 | ₹ 11,298 | 60.30 | 54.22 | 5,375.00 | 4,211.55 | -1.00% | 4.22% | 0.04% | 0.04% | 0.04% | 41.40 | - | - | 83.37% | - | 4,835.64 | - | 50.70 |
M Marksans Pharma | 237.40 | 6.60% | 27,91,834 | ₹ 10,761 | 27.40 | 37.19 | 358.70 | 130.00 | 12.51% | -4.75% | 52.18% | 419.47% | 1,136.46% | 4.43 | 0.27% | 15.03% | 18.97% | 7.37 | 213.71 | 256.48 | 52.93 |
A Ami Organics | 1,173.40 | -0.90% | 3,16,546 | ₹ 9,606 | 61.04 | 32.36 | 1,322.00 | 504.00 | -0.23% | 2.09% | 90.64% | 150.09% | 150.99% | 7.40 | 0.13% | 14.02% | 10.83% | 15.13 | 1,153.02 | 979.10 | 54.81 |
P Procter & Gamble Health | 5,082.50 | 0.07% | 3,192 | ₹ 8,437 | 34.26 | 54.22 | 5,850.00 | 4,641.15 | -2.83% | -4.25% | 7.70% | 15.31% | 26.42% | 13.78 | 5.13% | 30.56% | 47.62% | 128.93 | 5,187.86 | 5,266.19 | 45.51 |
A Akums Drugs & Pharma | 513.15 | 1.21% | 1,05,614 | ₹ 8,077 | 55.89 | 42.09 | 1,175.90 | 405.00 | 7.54% | -6.76% | -35.55% | -35.55% | -35.55% | 2.82 | - | 0.11% | 0.23% | - | 492.09 | - | 51.77 |
F FDC | 436.90 | 0.40% | 53,245 | ₹ 7,113 | 25.82 | 42.09 | 658.85 | 366.25 | 2.80% | 6.52% | -0.05% | 78.14% | 80.76% | 3.09 | - | 9.78% | 18.55% | 19.31 | 410.87 | 484.54 | 61.65 |
A Aarti Pharma Labs | 780.55 | -2.36% | 5,78,540 | ₹ 7,074 | 26.57 | 42.09 | 837.25 | 495.95 | 9.41% | 6.02% | 50.09% | 170.79% | 170.79% | 3.64 | 0.31% | 12.34% | 16.83% | 24.86 | 734.55 | 665.11 | 63.64 |
S Shilpa Medicare | 669.45 | 2.87% | 1,95,811 | ₹ 6,547 | 75.20 | 37.19 | 959.50 | 417.60 | 2.10% | -1.55% | 34.19% | 73.39% | 82.04% | 2.74 | - | -1.74% | 6.09% | 4.20 | 653.49 | 755.39 | 48.96 |
S Strides Pharma Science | 666.10 | 2.26% | 2,52,569 | ₹ 6,139 | 23.18 | 42.09 | 1,675.00 | 301.13 | 7.54% | -2.00% | -21.64% | 442.52% | 267.75% | 2.64 | 0.38% | - | 6.67% | - | 642.09 | 631.09 | 50.94 |
J Jeena Sikho Lifecare | 2,266.25 | -0.80% | 17,820 | ₹ 5,634 | 170.11 | 37.19 | 2,498.60 | 997.50 | -2.28% | 23.98% | 109.81% | 1,439.05% | 1,207.33% | 45.15 | 0.21% | 26.65% | 35.59% | 13.43 | 1,990.61 | 1,798.39 | 59.59 |
S Supriya Lifescience | 664.35 | 0.29% | 2,20,801 | ₹ 5,347 | 30.53 | 42.09 | 842.00 | 330.00 | -9.36% | -3.77% | 76.92% | 104.79% | 69.98% | 5.88 | 0.12% | 12.85% | 19.87% | 16.80 | 675.24 | 641.57 | 47.33 |
I Innova Captab | 907.50 | -2.63% | 68,924 | ₹ 5,193 | 41.95 | 42.09 | 1,260.00 | 421.35 | 1.11% | 8.29% | 96.90% | 67.62% | 67.62% | 5.97 | - | 24.58% | 14.31% | 18.56 | 851.44 | 855.65 | 58.41 |
H Hikal | 407.60 | 2.25% | 2,37,055 | ₹ 5,026 | 65.92 | 32.36 | 464.75 | 267.25 | -1.69% | 16.74% | 45.29% | 2.64% | 292.11% | 4.08 | 0.30% | 6.92% | 8.78% | 5.49 | 393.41 | 373.76 | 50.58 |
S Sun Pharma Advanced Research Co | 149.74 | 0.75% | 3,78,675 | ₹ 4,859 | - | 31.62 | 258.00 | 109.30 | 1.19% | 3.67% | -30.21% | -28.71% | 12.80% | 38.35 | - | -307.91% | -154.06% | - | 140.34 | 186.79 | 53.54 |
S Sequent Scientific | 167.52 | -1.00% | 9,66,949 | ₹ 4,193 | 330.88 | 42.09 | 240.70 | 92.05 | 16.24% | 6.22% | 44.60% | 49.57% | 106.05% | 6.21 | - | - | -0.72% | - | 145.52 | 169.10 | 67.58 |
A Aarti Drugs | 453.50 | 5.86% | 18,61,861 | ₹ 4,139 | 23.41 | 32.36 | 635.00 | 312.00 | 27.66% | 18.44% | -3.87% | 6.83% | 137.30% | 2.87 | 0.23% | 13.95% | 16.44% | 17.06 | 358.20 | 448.15 | 73.95 |
U Unichem Laboratories | 572.55 | 2.33% | 36,642 | ₹ 4,031 | 46.69 | 42.09 | 937.95 | 501.00 | -6.15% | -17.51% | 2.39% | 138.86% | 340.76% | 1.65 | - | -2.98% | -1.58% | - | 633.88 | 684.31 | 35.27 |
O Orchid Pharma | 794.75 | 1.19% | 1,10,083 | ₹ 4,031 | 36.16 | 42.09 | 1,997.40 | 684.35 | 5.17% | -24.10% | -21.69% | 153.39% | 4,315.28% | 3.26 | - | 8.13% | 8.37% | 21.99 | 824.55 | 1,308.84 | 45.14 |
G Gufic BioSciences | 372.10 | -1.42% | 22,896 | ₹ 3,731 | 46.24 | 42.09 | 504.25 | 278.00 | 9.30% | -8.35% | 15.61% | 66.38% | 549.96% | 6.60 | 0.03% | 22.92% | 18.19% | 8.59 | 347.38 | 397.82 | 58.61 |
R RPG Life Sciences | 2,148.00 | 2.76% | 72,988 | ₹ 3,553 | 29.24 | 42.09 | 2,974.95 | 1,381.00 | -0.93% | -9.73% | 43.20% | 354.60% | 802.33% | 6.52 | 1.15% | 23.39% | 30.97% | 55.82 | 2,164.38 | 2,244.50 | 46.73 |
G Gujarat Themis Biosyn | 308.05 | 2.26% | 2,45,397 | ₹ 3,357 | 62.02 | 32.36 | 330.45 | 208.00 | 10.61% | 26.53% | 26.53% | 26.53% | 26.53% | 14.61 | 0.22% | - | 38.82% | - | 266.78 | - | 62.68 |
P Panacea Biotec | 539.25 | 4.98% | 5,05,609 | ₹ 3,303 | - | 42.09 | 581.90 | 112.35 | 13.68% | 56.80% | 296.07% | 288.79% | 262.37% | 3.79 | - | - | 0.54% | - | 445.48 | 358.90 | 55.63 |
M Morepen Laboratories | 60.17 | -0.31% | 76,24,478 | ₹ 3,297 | 26.25 | 42.09 | 100.90 | 42.00 | 14.85% | 9.24% | 31.95% | 53.49% | 270.28% | 2.98 | 0.33% | 11.40% | 15.61% | 2.15 | 51.87 | 69.27 | 58.58 |
D Dishman Carbogen Amcis | 208.65 | 6.82% | 10,14,871 | ₹ 3,271 | - | 42.09 | 307.98 | 133.00 | -0.59% | -8.61% | 4.80% | 76.60% | 179.88% | 0.53 | - | -0.51% | -0.03% | - | 208.14 | 214.63 | 45.37 |
Z Zota Healthcare | 940.55 | 6.16% | 1,73,929 | ₹ 2,593 | - | 42.09 | 1,078.00 | 440.10 | 11.82% | 2.88% | 96.30% | 249.00% | 582.05% | 14.68 | 0.10% | -7.18% | -7.36% | - | 829.51 | 746.29 | 56.94 |
S Senores Pharmaceuticals | 545.45 | 6.83% | 6,95,193 | ₹ 2,512 | 74.54 | 37.19 | 665.00 | 435.25 | -2.99% | 0.95% | -2.08% | -2.08% | -2.08% | 3.05 | - | - | 9.19% | - | 550.24 | - | 44.70 |
I Indoco Remedies | 251.12 | 0.04% | 34,666 | ₹ 2,317 | 126.00 | 42.09 | 387.55 | 190.00 | 7.56% | 0.25% | -20.77% | -25.43% | 8.22% | 2.13 | 0.60% | 13.83% | 11.34% | 7.50 | 233.76 | 300.87 | 58.27 |
S SMS Pharmaceuticals | 254.05 | 3.63% | 1,99,753 | ₹ 2,151 | 32.90 | 32.36 | 398.00 | 175.25 | 19.88% | 23.97% | 26.74% | 208.50% | 548.09% | 3.54 | 0.16% | 0.84% | 12.75% | 6.73 | 215.35 | 262.77 | 62.48 |
Showing 50 of 106 results
Download CSVPlease Note:
- PE Ratio: Share Price/Earning Per Share
- PB Ratio: Market Cap/Book Value
- ROE: Net Income/Shareholder's Equity
- ROCE: Earning Before Interest & Tax (EBIT)/Capital Employed
- EPS: (Net Income-Preferred Dividend)/Weighted Average Number of Shares Outstanding
- 50 DMA: Simple Moving Average of the past 50 days closing prices for a stock.
- 200 DMA: Simple Moving Average of the past 200 days closing prices for a stock.
- RSI: Relative Strength Index (14) is a momentum indicator to measure price changes to analyse overbought/oversold conditions.
*The scrips mentioned above are just for research purpose and not recommendations. Please do your own due diligence before investing.
Frequently Asked Questions
When selecting small cap pharma stocks, prioritize companies with a promising pipeline of drugs, positive cash flow, and manageable debt levels. Focus on those involved in high-growth therapeutic areas or with recent regulatory approvals. It’s also essential to assess their market position and partnerships within the pharmaceutical industry.
Investing in small cap pharma stocks offers the potential for significant capital appreciation, especially if the company achieves a breakthrough in drug development or secures a major approval. These stocks are often in their growth phase, providing opportunities for attractive returns as the company expands and gains market share.
Small cap pharma stocks can be highly volatile due to the risks associated with drug development, such as failed trials or regulatory setbacks. These companies may also face liquidity issues and intense competition from larger, more established players. Thorough research and a strong understanding of the sector are crucial to mitigating these risks.
Small cap pharma stocks may be ideal for beginners based on their risk tolerance level. They are volatile and come with the complexities of the pharmaceutical industry. The risks involved in drug development and market competition can make these stocks challenging to evaluate. Beginners should consider diversifying their investments and gaining more market experience before venturing into small cap pharma stocks.
Small cap pharma stocks can be a suitable investment for those willing to accept higher risk in exchange for potentially competitive returns. These stocks may deliver substantial gains if the company successfully develops new drugs or enters lucrative markets. However, thorough research and a long-term perspective are essential to managing the inherent risks.
Join us on
Follow us on
Partner with us
built with love
for Indians who love to invest & trade
We are part of Raise Financial Services
Explore | Sitemap
*All securities mentioned on this website are exemplary and not recommendatory.
*Current prices on the website are delayed by 15 mins, login to check live prices.
We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.
Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.
That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.
©2021-2025 Moneylicious Securities Private Limited. All rights reserved. CIN: U74999MH2012PTC433549 Moneylicious Securities is part of Raise Financial Services.
SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India.
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.
For any query / feedback / clarifications, email at help@dhan.co.
Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details
Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India.
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.
Details of client bank account
For any query / feedback / clarifications, email at help@dhan.co.
In case of grievances for any of the services rendered by Moneylicious Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.
Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.
DHAN is a brand owned by Moneylicious Securities Private Limited. All DHAN clients are registered under Moneylicious Securities Private Limited. Clients are advised to refer to our company as Moneylicious Securities Private Limited when communicating with regulatory authorities.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances
Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit
Attention investors:
- Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
- Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
- Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.
Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / Moneylicious / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.
Moneylicious Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.
Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/
Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX
Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets
Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details
Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors